WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006020277) ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/020277    International Application No.:    PCT/US2005/025505
Publication Date: 23.02.2006 International Filing Date: 15.07.2005
IPC:
A61K 31/445 (2006.01), A61K 31/454 (2006.01), A61K 31/4545 (2006.01), C07D 413/14 (2006.01), C07D 417/14 (2006.01)
Applicants: MERCK & CO., INC. [US/US]; 126 East Lincoln Avenue, Rahway, New Jersey 07065-0907 (US) (For All Designated States Except US).
BAKSHI, Raman, K. [US/US]; (US) (For US Only).
DELLUREFICIO, James, P. [US/US]; (US) (For US Only).
NARGUND, Ravi, P. [US/US]; (US) (For US Only)
Inventors: BAKSHI, Raman, K.; (US).
DELLUREFICIO, James, P.; (US).
NARGUND, Ravi, P.; (US)
Common
Representative:
MERCK & CO., INC.; 126 East Lincoln Avenue, Rahway, New Jersey 07065-0907 (US)
Priority Data:
60/589,089 19.07.2004 US
Title (EN) ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS
(FR) DERIVES DE PIPERIDINE ACYLES UTILISES EN TANT QU'AGONISTES DU RECEPTEUR DE LA MELANOCORTINE 4
Abstract: front page image
(EN)Certain novel N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
(FR)L'invention concerne certains nouveaux dérivés de pipéridine acylés qui sont des agonistes des récepteurs humains de la mélanocortine et, en particulier, des agonistes sélectifs du récepteur humain de la mélanocortine 4 (MC-4R). Ces dérivés s'avèrent ainsi utiles pour le traitement, la prévention de maladies et de troubles associés à l'activation du MC-4R et pour la lutte contre ces maladies et troubles, par exemple l'obésité, le diabète, les troubles de la sexualité, notamment les troubles de l'érection et les troubles de la sexualité chez la femme.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)